View the 2018 Agenda
Join us in June for PharmaTrace Spring 2018 to candidly discuss strategies and tactics companies are using to meet those deadlines and optimize current processes. A feature of this spring’s event is our intimate discussion groups providing a unique platform for you to share your ...
Additional Content Download
Expert Insight into Top Pharmaceutical Challenges Surrounding Serialization: Aggregation and CMO Integration
In anticipation of the Pharmaceutical Traceability Forum, we spoke with Matt Sample and Christopher Howell about the top pharmaceutical challenges surrounding Serialization: Aggregation and CMO Integration. Both speakers shared their unique perspectives on the topic and also expressed what they were most excited to learn about at the upcoming event.
Preparing for 2023: Advice from a Top Wholesaler
In advance of the Forum, we spoke with an elite representative from the wholesaler side of pharmaceutical shipping about the plans his company has and the challenges he’s facing. Take these into consideration today for best results 7 years from now.
Tools of the Trace
Past speaker Peter Sturtevant, Sr. Director of Industry Engagement at GS1 US, discusses the tools which will help you achieve and surpass DSCSA compliance, such as the Electronic Product Code Information Service and the Master Data Exchange.
The Hidden Requirements of Enterprise Serialization Systems
Past speaker Scott Pugh, Principal at Jennason, talks about the key functionality, architecture, hosting, and deployment, implementation and validation of enterprise serialization systems in this past presentation.
Serialization: Driving Business Value Beyond Compliance
As serialization and track-and-trace capabilities go mainstream to meet regulatory compliance mandates, pharmaceuticals companies should simultaneously explore how these tools and techniques can improve supply chain planning and operations, elevate patient and doctor engagement, and increase sales and marketing effectiveness. Whitepaper courtesy of Cognizant.
Serialisation Case Studies: SMEs and CMOs
Pharma IQ spoke with Mark Davison, Chief Executive Officer at Blue Sphere Health Ltd, and Vetter Pharma to gain insight into SME pharma & biotechs for serialization, as well as strategies that CMOs can implement to succeed in serialization.
Pharmaceutical Traceability Industry Experts EBook
Before you hear from these great speakers at the Forum, read their thoughts on serialization within the life sciences industry. We sat down with speakers from top companies such as AmerisourceBergen, Merck & Co., NC Mutual Wholesale Drug Company and Neurocrine Biosciences, find out what they had to say!
Examining Serialization as a 21st Century Approach to Anti-Counterfeiting
Check out this webinar from Ben Locwin of Healthcare Sciences Advisors!
Achieving Scannable GS1 Codes for DSCSA Compliance
Take a look at this exclusive whitepaper put together by VideoJet. Within the paper you will find out more about how the DQSA and DSCSA compliance regulations can impact your overall operation.
Pharmaceutical Serialization and Traceability 2017 Trend Report
With time running low, Pharma Logistics IQ tracks the state of the industry’s serialization projects. This year’s research report maps out and measures the changes in consensus as the industry advances closer to an entirely track-and-trace pharmaceutical environment. Sections covered:Project PlanningImplementation ProgressTraceability In Operation Benefits Beyond Compliance
Serialization: An Implementation Guide
This white paper gives in-depth descriptions of the:Challenges driving new serialization regulation.Pending regulation requirements and deadlines.Implementation and interoperability challenges in serialization solutions.New holistic serialization solution from Rockwell Automation built on a modular and scalable off-the-shelf control and information platform.Business benefits of the common data source created by serialization.
Working with CMOs: Serialization Tends to Fail in the Details
This is the second article in a series looking at how to avoid the supply risk when working with CMOs on serialization. In this article I will discuss another six learnings covering everything from resource-planning to clarifying your RACI.
Implementing a Serialization Project Post DSCSA
Are you ready? The likely answer is no, but it’s just as likely that you are working on it. The fact is, the pharmaceutical industry is still wrestling with challenges which will continue to evolve as serialization systems are rolled out.
7 Steps To Implementing A Serialization Project
Take sneek peak at the 7 steps to implementing a full serialization project:1: Get ready for a cultural change.2: Invest in high volume items
Optel Acquires Verify Brand to Set the Stage for End-to-End Traceability
At the 6th Pharmaceutical Traceability Forum, Optel made an exciting industry announcement. Watch the live video here..
Electronic Product Code Information Services (EPCIS) “Push” Method
2017 Presentation! Distributed databasesSending EPCIS data (TI,TS) to forward trading partners.One-up, One-down visibilityPresentation by Peter Sturtevant Senior Director Industry Development, Pharmaceuticals GS1 US
Understanding Blockchain and DSCSA
2017 Presentations!Ensures your data requestors are legitimate with minimal effortDoes not require a central repositoryWorks seamlessly with GS1 EPCISPresentation by Robert Celeste, Founder, Center for Supply Chain Studies
The Final Stages of Serialization
Pharma IQ conducted extensive market research to pinpoint the concerns and priorities of those in the more mature phases of serialization.
Software Best Practises: Implementation & Data Integration
Effective data management is imperative to achieve regulatory compliance with a serialisation programme. Non-standard data exchange and integration methods are seen as one of the biggest hurdles in serialisation compliance. In light of the data responsibilities expected within serialisation projects, Pharma IQ consults with a selection of experts on software...
Top 10 Pharma and Biotech Trends to Watch in 2018
Pharma IQ takes a look at some of the trends forecasted to take hold this year: disruption for vendor landscapes, regulatory intervention and sophisticated analytics technologies gaining speed.
Traceability in Operation Market Research: Concerns and Priorities
Pharma IQ collected the following market research to pinpoint the concerns and priorities of those in the more mature phases of serialization. Commentary supplied by Pasi Kemppainen, Executive Consultant, Pharma Serialization and Traceability.
Drug Supply Chain Security Act (DSCSA) Interactive Implementation Timeline
The Drug Quality and Security Act (DQSA), was enacted by Congress on November 27, 2013. Title II of DQSA, the Drug Supply Chain Security Act (DSCSA), outlines steps to build an electronic, interoperable system to identify and trace certain prescription drugs as they are distributed in the United States. This...
Implementing Serialization in the Drug Supply Chain
Currently, the pharmaceutical industry uses tracking and tracing technology heavily in the upstream supply chain. Maintaining visibility of the source of Active Pharmaceutical Ingredients (API) is of utmost importance.Editor’s Note: Every year, 40 or so students in the MIT Center for Transportation & Logistics’ (MIT CTL) Master of Supply Chain...
Past Attendee Snapshot
We have you covered. From companies to job titles, here's a glance at some of the industry experts anticipated to be at this year's forum - many of whom you're likely to run into on the show floor this year.
Justify Your Trip Letter
Present your boss with this customizable letter detailing the reasons why you should attend the upcoming Pharmaceutical Traceability Forum.
Serialization World Map
Pharma IQ have created an updated serialisation printable world map to assist with your worldwide serialisation compliance strategies and help the industry prepare for these various approaching deadlines all over the globe.
FDA Vision For 2023
Ahead of the 6th Pharmaceutical Traceability Forum, December 7 -8, we interviewed members of our speaker faculty on their immediate impressions of the FDA meeting that was held in August. Get your copy of this exclusive interview to find out what the FDA vision of the future is for 2023!
2017 Post Show Report
Find out what you missed in 2017! Get the inside scoop on who attended, what they learned and how the benefited from attending the 2017 Pharma Tractability Forum.To receive this report via email, please contact us at email@example.com.